Publication|Articles|March 4, 2026
Supplements and Featured Publications
- The Cost of PCSK9 mAb Waste: Results From a Patient-Reported Survey on PCSK9 mAb Compliance and Discontinuation
The Cost of PCSK9 mAb Waste: Results From a Patient-Reported Survey on PCSK9 mAb Compliance and Discontinuation
Advertisement
This clinical brief is sponsored by Novartis.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
DOJ Abandons Olmstead Defense as Texas v Kennedy Advances
2
FDA Expands Tirzepatide Label to Reduce Cardiovascular Risk in Type 2 Diabetes
3
Myasthenia Gravis Linked to Greater Longevity Than Multiple Sclerosis
4
FDA Approves Rusfertide to Treat Erythrocytosis In Polycythemia Vera
5